On Oct. 9, Presbyterian Hospital became the first hospital the southeast to implant a Subcutaneous Implantable Cardioverter Defibrillator (S-ICD), following the Food and Drug Administration’s post clinical trial approval of the device Sept. 28. The procedure was the third nationwide, following FDA approval.
The S-ICD is the first heart defibrillator that can be implanted just under the skin (subcutaneously) instead of being connected directly into the heart. Other implantable difibrilators require physicians to insert one or more electrical leads through the vein and into the heart, which can increase the chance of complications.
For patients at risk of sudden cardiac arrest, defibrillators deliver a shock to the heart muscle to restore normal heart rhythm.
Dr. Mark Kremers at Mid Carolina Cardiology was one of the lead investigators in clinical trials of the S-ICD and performed the first S-ICD implantation in the southeast, following FDA approval.
More information on S-ICD
More information on the S-ICD can be found in this press release from the FDA.
Marketing & Public Relations, 704-384-4119